an urgent call for health equity in breast cancer€¦ · lynn sage breast cancer symposium...
TRANSCRIPT
Komens continued focus on Breast Cancer Disparities Menrsquos HealthMonth
An Urgent Call for Health Equity in Breast Cancer
Addressing breast cancer healthdisparities is at the forefront of whatSusan G Komen does Komen CEOJudy Salerno wrote about the pressingimportance of addressing thesedisparities and the key steps Komen istaking in this fight in a powerfulHuffington Post blog post You can readher post and learn more about whereresearch fits into our larger approach toachieving health equity here
Continuing on this theme Dr Salernoalso recently published an article abouthow Komenrsquos efforts to understand andeliminate health disparities fit into thebroader priorities of Vice President JoeBidenrsquos Cancer Moonshot You can findthis piece on the Cancer Moonshotwebsite here
A Focus on Menrsquos Breast Cancer for Menrsquos Health Month
Subscribe Share Past Issues Translate
During the month of June Komenhonored Menrsquos Health Month bypublishing two blog posts featuring malebreast cancer survivors The first postwhich you can read here featured oneof our recent helpline callers and sharedsome important warning signs of breastcancer in men The second post sharedthe personal story of male breast cancersurvivor and advocate Wayne Dornanand why he now wears his diagnosis asa badge of honor You can read that posthere
Komen Leadership News and Views
Transforming Womenrsquos Health in BosniaIn addition to her piece on breast cancerhealth equity Dr Salerno also wrote ablog for the Huffington Post on herrecent visit to Bosnia where she learnedfirsthand about the power ofpartnerships While there Dr Salernomet with members of the AmericanJewish Joint Distribution Committee(JDC) with whom Komen jointly fundsthe Womenrsquos Health EmpowermentProgram (WHEP) You can read moreabout the WHEP and Dr Salernorsquosmoving experience here
Funding Opportunity Announcement
The 2016shy2017 Komen Graduate Training in Disparities Research (GTDR) Applicationdeadline is September 20 at 1 pm EST
GTDR Grants are intended to establish andor to sustain a training programdedicated to understanding and eliminating disparities in breast cancer outcomesacross population groupsFor more information please visit wwwkomenorgRFA
Coming soon We will be releasing the Request for Applications for the next round ofShevell Travel Awards early this fall
Subscribe Share Past Issues Translate
Komen Research Highlights
Komen Recognized by ASCO for Investment in CancerLinQ
The American Society of ClinicalOncology (ASCO) recently recognizedSusan G Komen for our $2 million dollarinvestment in CancerLinQ a big dataproject that aims to rapidly improve theoverall quality of cancer care You canlearn more about this excitingtechnology and our partnership withASCOrsquos Conquer Cancer Foundationhere
Upcoming ConferencesSusan G Komen partners with other breast cancer organizations professionalsocieties and academic institutions to support a number of patientshyfocused meetingsand scientific conferences each year Below is a list of Komenshysponsored meetings ()as well as other conferences that may be of interest
30th Conference of the International Association for Breast Cancer Research(IABCR) (Portland OR) ndash Aug 4shy7Lynn Sage Breast Cancer Symposium (Chicago IL) ndash Sept 22shy259th AACR Conference on the Science of Cancer Health Disparities inRacialEthnic Minorities and the Medically Underserved (Ft Lauderdale FL) ndashSept 25shy281st International Invasive Lobular Cancer (ILC) Symposium (Pittsburgh PA) ndashSept 29shy3010th Annual Joining FORCEs Against Hereditary Cancer Conference (OrlandoFL) ndash Oct 6shy8American Public Health Association (APHA) 2016 Annual Meeting (Denver CO)ndash Oct 29shyNov 22016 San Antonio Breast Cancer Symposium (SABCS) (San Antonio TX) ndash Dec6shy10
If you will be presenting your Komenshyfunded research at any of these conferences andif you need the Komen logo to include on your poster or presentation please be sure tolet your Research Grants Manager know or email us atresearchprogramskomenorg
Komen Kudos
In early June Susan G Komen praised Senate
Subscribe Share Past Issues Translate
leaders for swift action to preserve federal funding ofbiomedical research ndash including breast cancerresearch ndash conducted through the Department ofDefense (DOD) You can read more about thisimportant amendment here
Komen Research in the News
PM 360 mdash According to a Komenshyfunded study the combination of a 21shygenerecurrence score and quantitative estrogen receptor expression may helpclinicians identify patients with estrogen receptorndashpositive breast cancer who aremost likely to benefit from hormonal therapy extended beyond the customary fiveyears Health Canal mdash A multishyinstitutional team of scientists funded by Komencompleted the first largeshyscale ldquoproteogenomicrdquo study of breast cancer linkingDNA mutations to protein signaling and helping pinpoint the genes that drivecancerMedical Xpress mdash According to a Komenshyfunded study published in ScienceAdvances researchers have shown that using a drug combination that targetsboth the progesterone receptor and estrogen receptors (using tamoxifen) is moreeffective at treating some breast cancers than tamoxifen aloneMedscape mdash Komen funding helped support two studies from the clinical trialcollaboration known as the Investigation of Serial Studies to Predict YourTherapeutic Response through Imaging and Molecular Analysis 2 (IshySPY 2) Thestudies provide evidence for the effectiveness of two new drugs (neratinib andveliparib in combination with carboplatin) in the neoadjuvant treatment of breastcancerBoston Business Journal mdash Fitbit announced it is partnering with BostonsDanashyFarber Cancer Institute on a study led by Komen Scholar Dr JenniferLigibel to determine whether exercise helps decrease the recurrence of breastcancer
Copyright copy 2016 Susan G Komenreg All rights reserved
unsubscribe from this list update subscription preferences
Subscribe Share Past Issues Translate
Subscribe Share Past Issues Translate
During the month of June Komenhonored Menrsquos Health Month bypublishing two blog posts featuring malebreast cancer survivors The first postwhich you can read here featured oneof our recent helpline callers and sharedsome important warning signs of breastcancer in men The second post sharedthe personal story of male breast cancersurvivor and advocate Wayne Dornanand why he now wears his diagnosis asa badge of honor You can read that posthere
Komen Leadership News and Views
Transforming Womenrsquos Health in BosniaIn addition to her piece on breast cancerhealth equity Dr Salerno also wrote ablog for the Huffington Post on herrecent visit to Bosnia where she learnedfirsthand about the power ofpartnerships While there Dr Salernomet with members of the AmericanJewish Joint Distribution Committee(JDC) with whom Komen jointly fundsthe Womenrsquos Health EmpowermentProgram (WHEP) You can read moreabout the WHEP and Dr Salernorsquosmoving experience here
Funding Opportunity Announcement
The 2016shy2017 Komen Graduate Training in Disparities Research (GTDR) Applicationdeadline is September 20 at 1 pm EST
GTDR Grants are intended to establish andor to sustain a training programdedicated to understanding and eliminating disparities in breast cancer outcomesacross population groupsFor more information please visit wwwkomenorgRFA
Coming soon We will be releasing the Request for Applications for the next round ofShevell Travel Awards early this fall
Subscribe Share Past Issues Translate
Komen Research Highlights
Komen Recognized by ASCO for Investment in CancerLinQ
The American Society of ClinicalOncology (ASCO) recently recognizedSusan G Komen for our $2 million dollarinvestment in CancerLinQ a big dataproject that aims to rapidly improve theoverall quality of cancer care You canlearn more about this excitingtechnology and our partnership withASCOrsquos Conquer Cancer Foundationhere
Upcoming ConferencesSusan G Komen partners with other breast cancer organizations professionalsocieties and academic institutions to support a number of patientshyfocused meetingsand scientific conferences each year Below is a list of Komenshysponsored meetings ()as well as other conferences that may be of interest
30th Conference of the International Association for Breast Cancer Research(IABCR) (Portland OR) ndash Aug 4shy7Lynn Sage Breast Cancer Symposium (Chicago IL) ndash Sept 22shy259th AACR Conference on the Science of Cancer Health Disparities inRacialEthnic Minorities and the Medically Underserved (Ft Lauderdale FL) ndashSept 25shy281st International Invasive Lobular Cancer (ILC) Symposium (Pittsburgh PA) ndashSept 29shy3010th Annual Joining FORCEs Against Hereditary Cancer Conference (OrlandoFL) ndash Oct 6shy8American Public Health Association (APHA) 2016 Annual Meeting (Denver CO)ndash Oct 29shyNov 22016 San Antonio Breast Cancer Symposium (SABCS) (San Antonio TX) ndash Dec6shy10
If you will be presenting your Komenshyfunded research at any of these conferences andif you need the Komen logo to include on your poster or presentation please be sure tolet your Research Grants Manager know or email us atresearchprogramskomenorg
Komen Kudos
In early June Susan G Komen praised Senate
Subscribe Share Past Issues Translate
leaders for swift action to preserve federal funding ofbiomedical research ndash including breast cancerresearch ndash conducted through the Department ofDefense (DOD) You can read more about thisimportant amendment here
Komen Research in the News
PM 360 mdash According to a Komenshyfunded study the combination of a 21shygenerecurrence score and quantitative estrogen receptor expression may helpclinicians identify patients with estrogen receptorndashpositive breast cancer who aremost likely to benefit from hormonal therapy extended beyond the customary fiveyears Health Canal mdash A multishyinstitutional team of scientists funded by Komencompleted the first largeshyscale ldquoproteogenomicrdquo study of breast cancer linkingDNA mutations to protein signaling and helping pinpoint the genes that drivecancerMedical Xpress mdash According to a Komenshyfunded study published in ScienceAdvances researchers have shown that using a drug combination that targetsboth the progesterone receptor and estrogen receptors (using tamoxifen) is moreeffective at treating some breast cancers than tamoxifen aloneMedscape mdash Komen funding helped support two studies from the clinical trialcollaboration known as the Investigation of Serial Studies to Predict YourTherapeutic Response through Imaging and Molecular Analysis 2 (IshySPY 2) Thestudies provide evidence for the effectiveness of two new drugs (neratinib andveliparib in combination with carboplatin) in the neoadjuvant treatment of breastcancerBoston Business Journal mdash Fitbit announced it is partnering with BostonsDanashyFarber Cancer Institute on a study led by Komen Scholar Dr JenniferLigibel to determine whether exercise helps decrease the recurrence of breastcancer
Copyright copy 2016 Susan G Komenreg All rights reserved
unsubscribe from this list update subscription preferences
Subscribe Share Past Issues Translate
Subscribe Share Past Issues Translate
Komen Research Highlights
Komen Recognized by ASCO for Investment in CancerLinQ
The American Society of ClinicalOncology (ASCO) recently recognizedSusan G Komen for our $2 million dollarinvestment in CancerLinQ a big dataproject that aims to rapidly improve theoverall quality of cancer care You canlearn more about this excitingtechnology and our partnership withASCOrsquos Conquer Cancer Foundationhere
Upcoming ConferencesSusan G Komen partners with other breast cancer organizations professionalsocieties and academic institutions to support a number of patientshyfocused meetingsand scientific conferences each year Below is a list of Komenshysponsored meetings ()as well as other conferences that may be of interest
30th Conference of the International Association for Breast Cancer Research(IABCR) (Portland OR) ndash Aug 4shy7Lynn Sage Breast Cancer Symposium (Chicago IL) ndash Sept 22shy259th AACR Conference on the Science of Cancer Health Disparities inRacialEthnic Minorities and the Medically Underserved (Ft Lauderdale FL) ndashSept 25shy281st International Invasive Lobular Cancer (ILC) Symposium (Pittsburgh PA) ndashSept 29shy3010th Annual Joining FORCEs Against Hereditary Cancer Conference (OrlandoFL) ndash Oct 6shy8American Public Health Association (APHA) 2016 Annual Meeting (Denver CO)ndash Oct 29shyNov 22016 San Antonio Breast Cancer Symposium (SABCS) (San Antonio TX) ndash Dec6shy10
If you will be presenting your Komenshyfunded research at any of these conferences andif you need the Komen logo to include on your poster or presentation please be sure tolet your Research Grants Manager know or email us atresearchprogramskomenorg
Komen Kudos
In early June Susan G Komen praised Senate
Subscribe Share Past Issues Translate
leaders for swift action to preserve federal funding ofbiomedical research ndash including breast cancerresearch ndash conducted through the Department ofDefense (DOD) You can read more about thisimportant amendment here
Komen Research in the News
PM 360 mdash According to a Komenshyfunded study the combination of a 21shygenerecurrence score and quantitative estrogen receptor expression may helpclinicians identify patients with estrogen receptorndashpositive breast cancer who aremost likely to benefit from hormonal therapy extended beyond the customary fiveyears Health Canal mdash A multishyinstitutional team of scientists funded by Komencompleted the first largeshyscale ldquoproteogenomicrdquo study of breast cancer linkingDNA mutations to protein signaling and helping pinpoint the genes that drivecancerMedical Xpress mdash According to a Komenshyfunded study published in ScienceAdvances researchers have shown that using a drug combination that targetsboth the progesterone receptor and estrogen receptors (using tamoxifen) is moreeffective at treating some breast cancers than tamoxifen aloneMedscape mdash Komen funding helped support two studies from the clinical trialcollaboration known as the Investigation of Serial Studies to Predict YourTherapeutic Response through Imaging and Molecular Analysis 2 (IshySPY 2) Thestudies provide evidence for the effectiveness of two new drugs (neratinib andveliparib in combination with carboplatin) in the neoadjuvant treatment of breastcancerBoston Business Journal mdash Fitbit announced it is partnering with BostonsDanashyFarber Cancer Institute on a study led by Komen Scholar Dr JenniferLigibel to determine whether exercise helps decrease the recurrence of breastcancer
Copyright copy 2016 Susan G Komenreg All rights reserved
unsubscribe from this list update subscription preferences
Subscribe Share Past Issues Translate
Subscribe Share Past Issues Translate
leaders for swift action to preserve federal funding ofbiomedical research ndash including breast cancerresearch ndash conducted through the Department ofDefense (DOD) You can read more about thisimportant amendment here
Komen Research in the News
PM 360 mdash According to a Komenshyfunded study the combination of a 21shygenerecurrence score and quantitative estrogen receptor expression may helpclinicians identify patients with estrogen receptorndashpositive breast cancer who aremost likely to benefit from hormonal therapy extended beyond the customary fiveyears Health Canal mdash A multishyinstitutional team of scientists funded by Komencompleted the first largeshyscale ldquoproteogenomicrdquo study of breast cancer linkingDNA mutations to protein signaling and helping pinpoint the genes that drivecancerMedical Xpress mdash According to a Komenshyfunded study published in ScienceAdvances researchers have shown that using a drug combination that targetsboth the progesterone receptor and estrogen receptors (using tamoxifen) is moreeffective at treating some breast cancers than tamoxifen aloneMedscape mdash Komen funding helped support two studies from the clinical trialcollaboration known as the Investigation of Serial Studies to Predict YourTherapeutic Response through Imaging and Molecular Analysis 2 (IshySPY 2) Thestudies provide evidence for the effectiveness of two new drugs (neratinib andveliparib in combination with carboplatin) in the neoadjuvant treatment of breastcancerBoston Business Journal mdash Fitbit announced it is partnering with BostonsDanashyFarber Cancer Institute on a study led by Komen Scholar Dr JenniferLigibel to determine whether exercise helps decrease the recurrence of breastcancer
Copyright copy 2016 Susan G Komenreg All rights reserved
unsubscribe from this list update subscription preferences
Subscribe Share Past Issues Translate
Subscribe Share Past Issues Translate
Subscribe Share Past Issues Translate